Feature story

Gervinho meets young people affected by HIV in Gabon ahead of CAN 2017

19 January 2017

Travelling to Gabon to attend the Africa Cup of Nations (CAN 2017), Gervais Yao Kouassi (Gervinho), UNAIDS Special Ambassador for Youth and China–Africa Collaboration, visited the UNAIDS office in Libreville, Gabon, to meet some 50 children and young people living with or affected by HIV.

Accompanied by young Gabonese ambassadors for HIV and by artist Charly Tchatch, the animator of the opening of CAN 2017 and an AIDS activist, the international football star talked to the children and young people and listened to their stories and concerns. The children and young people talked about problems with accepting their status and stigma and depression, but also about happiness, love and how they deal with their daily problems.

“I am very touched. It is the first time I hear such poignant testimonies”, said Gervinho. “As you know, I wanted to play with my team here, but I am injured. Your mental strength and joy of life encourages me to face life’s challenges.” Gervinho signed the Protect the Goal campaign ball to support UNAIDS’ vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths at CAN 2017.

Inge Tack, the UNAIDS Country Director, mentioned to Gervinho that despite AIDS budget cuts of 60% in Gabon since 2012, treatment rates have doubled and new HIV infections have been reduced by 30%, while paediatric treatment rates have tripled and coverage of prevention of mother-to-child transmission is at 78%. However, she also noted the need to improve the management of HIV treatment provision to achieve the 90–90–90 targets. “A radical shift in the organization and management of treatment delivery services is required to achieve the 90–90–90 targets in Gabon. Medicines need to be in the centre at all times and services reoriented to better serve patients’ needs,” said Ms Tack.

Gabon experiences persistent treatment stock-outs and poor care services result in no treatment adherence follow-up, no monitoring of drug resistance and no viral load measurement. Ms Tack stressed the need for a decentralized approach for the provision of antiretroviral therapy and an increase in community-led services.